Autor: |
R, Montagnac, P, Clavel, B, Delhotal-Landes, B, Flouvat, S, Poulain, F, Schllinger |
Rok vydání: |
2001 |
Předmět: |
|
Zdroj: |
Clinical nephrology. 56(2) |
ISSN: |
0301-0430 |
Popis: |
Chronic hypotension, infrequent though possible in chronic renal failure patients on hemodialysis, has harmful consequences on their physical state and hence general well-being. These patients often experience acute intradialytic manifestations while non-pharmacologic interventions as pharmacologic agents are sometimes insufficient to improve symptoms. Well tolerated, midodrine appears to be a suitable and effective agent as it raises blood pressure significantly via its effect on peripheral alpha-adrenergic receptors. The authors describe their use of midodrine in a dialysis patient for the longest period of time reported up to now, documented by a pharmacokinetic study, confirming long-term both clinical efficacy and safety of the drug. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|